Vijay Chopra of enochventures.com told CNBC-TV18, "In Sun Pharma we have seen a very smart move from Rs 535 levels odd to Rs 570. So it has given Rs 30-40 decent up move. Another point is that their Halol plant inspection is on the way and the way company is giving the commentary, they are quite confident that they would get the approval for their plant."
"It has been in a zone where I think once it crosses Rs 650, it has a potential of reaching Rs 750-800 again. So it requires some kind of patience. So hold on to the stock and to your horses I would recommend and I am sure that Sun Pharmaceutical is either bottomed out or in the process of bottoming out and we will see a decent breakout in the coming days," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!